Show simple item record

dc.contributor.authorHernando Ortiz, Ainara ORCID
dc.contributor.authorMateo Alesanco, Estibaliz ORCID
dc.contributor.authorPérez Rodríguez, Aitzol ORCID
dc.contributor.authorDe Groot, Piet W. J.
dc.contributor.authorQuindós Andrés, Guillermo
dc.contributor.authorEraso Barrio, María Elena ORCID
dc.date.accessioned2021-05-21T07:30:28Z
dc.date.available2021-05-21T07:30:28Z
dc.date.issued2021-01-01
dc.identifier.citationVirulence 12(1) : 1063-1075 (2021)es_ES
dc.identifier.issn2150-5594
dc.identifier.issn2150-5608
dc.identifier.urihttp://hdl.handle.net/10810/51518
dc.description.abstractCandida auris is an emerging multidrug-resistant fungal pathogen responsible for nosocomial outbreaks of invasive candidiasis. Although several studies on the pathogenicity of this species have been reported, the knowledge on C. auris virulence is still limited. This study aims to analyze the pathogenicity of C. auris, using one aggregating isolate and eleven non-aggregating isolates from different clinical origins (blood, urine and oropharyngeal specimens) in two alternative host models of candidiasis: Caenorhabditis elegans and Galleria mellonella. Furthermore, possible associations between virulence, aggregation, biofilm-forming capacity, and clinical origin were assessed. The aggregating phenotype isolate was less virulent in both in vivo invertebrate infection models than non-aggregating isolates but showed higher capacity to form biofilms. Blood isolates were significantly more virulent than those isolated from urine and respiratory specimens in the G. mellonella model of candidiasis. We conclude that both models of candidiasis present pros and cons but prove useful to evaluate the virulence of C. auris in vivo. Both models also evidence the heterogeneity in virulence that this species can develop, which may be influenced by the aggregative phenotype and clinical origin.es_ES
dc.description.sponsorshipThis work was supported by the Euskal Herriko Unibertsitatea [PIF 16/39]; Euskal Herriko Unibertsitatea [PIF17/167]; Eusko Jaurlaritza [GIC15/78 IT-990-16]; Ministerio de Economia y Competitividad [SAF2017-86188-P].es_ES
dc.language.isoenges_ES
dc.publisherTaylor & Francises_ES
dc.relationinfo:eu-repo/grantAgreement/MICINN/SAF2017-86188-Pes_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.subjectCandida aurises_ES
dc.subjectemerging pathogenes_ES
dc.subjectcandidiasises_ES
dc.subjectvirulencees_ES
dc.subjectinvertebrate modelses_ES
dc.titleVirulence of Candida Auris from Different Clinical Origins in Caenorhabditis Elegans and Galleria Mellonella Host Modelses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.holderThis is an open access article distributed under the terms of the Creative Commons CC BY licensees_ES
dc.rights.holderAtribución 3.0 España*
dc.relation.publisherversionhttps://www.tandfonline.com/doi/full/10.1080/21505594.2021.1908765es_ES
dc.departamentoesInmunología, microbiología y parasitologíaes_ES
dc.departamentoeuImmunologia, mikrobiologia eta parasitologiaes_ES


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

This is an open access article distributed under the terms of the Creative Commons CC BY license
Except where otherwise noted, this item's license is described as This is an open access article distributed under the terms of the Creative Commons CC BY license